203 related articles for article (PubMed ID: 21156224)
1. MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application.
Nana-Sinkam SP; Croce CM
Cancer Genet Cytogenet; 2010 Dec; 203(2):127-33. PubMed ID: 21156224
[TBL] [Abstract][Full Text] [Related]
2. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia.
Calin GA; Pekarsky Y; Croce CM
Best Pract Res Clin Haematol; 2007 Sep; 20(3):425-37. PubMed ID: 17707831
[TBL] [Abstract][Full Text] [Related]
3. Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance.
Calin GA; Croce CM
Semin Oncol; 2006 Apr; 33(2):167-73. PubMed ID: 16616063
[TBL] [Abstract][Full Text] [Related]
4. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.
Pekarsky Y; Santanam U; Cimmino A; Palamarchuk A; Efanov A; Maximov V; Volinia S; Alder H; Liu CG; Rassenti L; Calin GA; Hagan JP; Kipps T; Croce CM
Cancer Res; 2006 Dec; 66(24):11590-3. PubMed ID: 17178851
[TBL] [Abstract][Full Text] [Related]
5. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in chronic lymphocytic leukemia.
Ward BP; Tsongalis GJ; Kaur P
Exp Mol Pathol; 2011 Apr; 90(2):173-8. PubMed ID: 21168405
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
[TBL] [Abstract][Full Text] [Related]
8. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis.
Marton S; Garcia MR; Robello C; Persson H; Trajtenberg F; Pritsch O; Rovira C; Naya H; Dighiero G; Cayota A
Leukemia; 2008 Feb; 22(2):330-8. PubMed ID: 17989717
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotype-related microRNA expression in canine chronic lymphocytic leukemia.
Gioia G; Mortarino M; Gelain ME; Albonico F; Ciusani E; Forno I; Marconato L; Martini V; Comazzi S
Vet Immunol Immunopathol; 2011 Aug; 142(3-4):228-35. PubMed ID: 21663977
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in the pathogeny of chronic lymphocytic leukaemia.
Nicoloso MS; Kipps TJ; Croce CM; Calin GA
Br J Haematol; 2007 Dec; 139(5):709-16. PubMed ID: 18021085
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in microRNA-mediated gene regulation in chronic lymphocytic leukemia.
Srivastava S; Tsongalis GJ; Kaur P
Clin Biochem; 2013 Jul; 46(10-11):901-8. PubMed ID: 23518313
[TBL] [Abstract][Full Text] [Related]
12. All you need is a Mir-acle: the role of nontranslated RNAs in the suppression of B cell chronic lymphocytic leukemia.
Lichter P
Cancer Cell; 2010 Jan; 17(1):3-4. PubMed ID: 20129242
[TBL] [Abstract][Full Text] [Related]
13. Role of microRNAs in chronic lymphocytic leukemia (Review).
Zhou XX; Wang X
Mol Med Rep; 2013 Sep; 8(3):719-25. PubMed ID: 23900739
[TBL] [Abstract][Full Text] [Related]
14. Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?
Caligaris-Cappio F; Ghia P
J Clin Oncol; 2008 Sep; 26(27):4497-503. PubMed ID: 18662968
[TBL] [Abstract][Full Text] [Related]
15. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY
Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076
[TBL] [Abstract][Full Text] [Related]
16. Animal models for chronic lymphocytic leukemia.
Pekarsky Y; Zanesi N; Aqeilan RI; Croce CM
J Cell Biochem; 2007 Apr; 100(5):1109-18. PubMed ID: 17131382
[TBL] [Abstract][Full Text] [Related]
17. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.
Meyer-Rochow GY; Jackson NE; Conaglen JV; Whittle DE; Kunnimalaiyaan M; Chen H; Westin G; Sandgren J; Stålberg P; Khanafshar E; Shibru D; Duh QY; Clark OH; Kebebew E; Gill AJ; Clifton-Bligh R; Robinson BG; Benn DE; Sidhu SB
Endocr Relat Cancer; 2010 Sep; 17(3):835-46. PubMed ID: 20621999
[TBL] [Abstract][Full Text] [Related]
19. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
Mirzaei H; Fathullahzadeh S; Khanmohammadi R; Darijani M; Momeni F; Masoudifar A; Goodarzi M; Mardanshah O; Stenvang J; Jaafari MR; Mirzaei HR
J Cell Physiol; 2018 Feb; 233(2):888-900. PubMed ID: 28084621
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters?
Molica S
Haematologica; 1997; 82(6):705-9. PubMed ID: 9499672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]